This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
The introduction of fentanyl, a potent synthetic opioid, into the U.S. drug supply has remade the landscape for health and recovery. This includes changing norms around the use of methadone, a common treatment option for opioid use disorder.
A new paper published in Health and Quality of Life Outcomes identified a positive association between higher methadone doses and patient quality of life.
This work was led by Shadi Izadidehkordi, a postdoctoral research associate, and Michael Copenhaver, a professor of health promotion, in the Department of Allied Health Sciences in the College of Agriculture, Health and Natural Resources (CAHNR).
Methadone has been used to treat opioid use disorder for decades. The drug works by occupying the same receptors as opioids like fentanyl or heroin. It reduces withdrawal symptoms and cravings and makes the highs and crashes experienced with illicit opioids less intense.
"Like fentanyl, methadone is a synthetic opioid," Izadidehkordi says. "It's sitting on the same receptors. But it lowers the intensity of cravings and withdrawals. When those symptoms are controlled with a maintained methadone dose, it brings some level of stability back into their lives, preventing their addiction from disrupting their day-to-day life."
Patients need to be present in a drug treatment program to receive their daily methadone dose. Methadone clinics start patients at a low dose that does not have a pharmacologically significant effect before eventually ramping up to a standard long-term dose.
Source link







